10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?
Serge SaxonovChief Executive Officer2024-03-044,660$44.00
Serge SaxonovChief Executive Officer2024-02-222,821$46.34
Justin J. McAnearChief Financial Officer2024-02-221,865$46.34
Benjamin J. HindsonPresident and Chief Scientific Officer2024-02-222,613$46.34
Serge SaxonovChief Executive Officer2024-02-151,700$49.43
Serge SaxonovChief Executive Officer2024-02-153,300$48.58
Serge SaxonovChief Executive Officer2024-02-091,000$49.53
Serge SaxonovChief Executive Officer2024-01-162,965$45.10
Serge SaxonovChief Executive Officer2024-01-161,035$45.65
Benjamin J. HindsonPresident and Chief Scientific Officer2023-12-288,334$11.48

1 of 6

TXG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?
Fmr LLC10.73%12,785,536$355.44MInstitution
Vanguard Group Inc7.56%9,011,332$250.52MInstitution
Baillie Gifford Co6.65%7,919,976$220.18MInstitution
Blackrock Inc4.79%5,705,392$158.61MInstitution
Paladin Capital Management LLC4.71%5,617,583$156.17MInsider
Bryan E. Roberts3.64%4,336,630$120.56MInsider
Morgan Stanley3.51%4,179,415$116.19MInstitution
Ark Investment Management LLC3.39%4,041,287$112.35MInstitution
Softbank Vision Fund Aiv M2 LP3.22%3,836,232$106.65MInsider
Sands Capital Management LLC3.01%3,590,145$99.81MInstitution

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG80.47%15.52%Net BuyingNet Selling
PGNY73.38%26.62%Net SellingNet Selling
EVH89.65%10.35%Net SellingNet Selling
GDRX35.86%10.61%Net SellingNet Selling
CERT73.33%26.67%Net SellingNet Selling

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 80.47% institutional shareholders, 15.52% 10x Genomics insiders, and 4.01% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.71% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $154.93M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.